INSULET CORPORATION (PODD) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 744.20M USD | Liabilities, Current |
| Cash and equivalents | (m) | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Customer receivables | 588.70M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 484.80M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $744.20M | (m) | (m) | $588.70M | $484.80M | (m) |
| 2026-03-31 | (m) | $687.50M | (m) | (m) | $544.70M | $462.50M | (m) |
| 2025-12-31 | (m) | $680.10M | (m) | (m) | (m) | $452.60M | (m) |
| 2025-09-30 | (m) | $647.70M | (m) | (m) | (m) | $446.30M | (m) |
| 2025-06-30 | (m) | $1.01B | (m) | (m) | (m) | $446.90M | (m) |
| 2025-03-31 | (m) | $520.40M | (m) | (m) | (m) | $440.80M | (m) |
| 2024-12-31 | (m) | $528.40M | (m) | (m) | (m) | $430.40M | (m) |
| 2024-09-30 | (m) | $506.20M | (m) | (m) | (m) | $444.90M | (m) |
| 2024-06-30 | (m) | $486.00M | (m) | (m) | (m) | $430.90M | (m) |
| 2024-03-31 | (m) | $432.40M | (m) | (m) | (m) | $430.60M | (m) |
| 2023-12-31 | (m) | $451.20M | (m) | (m) | (m) | $402.60M | (m) |
| 2023-09-30 | (m) | $451.40M | (m) | (m) | (m) | $410.80M | (m) |
| 2023-06-30 | (m) | $425.00M | (m) | (m) | (m) | $411.30M | (m) |
| 2023-03-31 | (m) | $383.30M | (m) | (m) | $159.60M | $386.10M | (m) |
| 2022-12-31 | (m) | $364.70M | (m) | (m) | $140.90M | $346.80M | (m) |
| 2022-09-30 | (m) | $334.20M | (m) | (m) | $153.10M | $327.60M | (m) |
| 2022-06-30 | (m) | $279.30M | (m) | (m) | $154.10M | $320.40M | (m) |
| 2022-03-31 | (m) | $215.00M | (m) | (m) | $153.50M | $314.80M | (m) |
| 2021-12-31 | (m) | $228.80M | (m) | $0.00 | $161.00M | $303.20M | (m) |
| 2021-09-30 | $971.40M | $228.60M | $856.60M | $500.00K | $114.30M | $259.00M | 4.25× |
| 2021-06-30 | $972.40M | $213.30M | $854.60M | $17.50M | $100.30M | $197.80M | 4.56× |
| 2021-03-31 | $948.10M | $185.50M | $820.70M | $29.50M | $97.90M | $170.10M | 5.11× |
| 2020-12-31 | $1.03B | $207.80M | $907.20M | $40.40M | $83.80M | $154.30M | 4.96× |
| 2020-09-30 | $982.10M | $175.20M | $838.10M | $58.60M | $85.40M | $124.90M | 5.61× |
| 2020-06-30 | $922.40M | $134.40M | $779.10M | $65.30M | $78.00M | $103.70M | 6.86× |
| 2020-03-31 | $401.70M | $130.40M | $201.40M | $120.20M | $80.10M | $95.70M | 3.08× |
| 2019-12-31 | $445.40M | $157.70M | $213.70M | $162.40M | $69.30M | $101.00M | 2.82× |
| 2019-09-30 | $670.56M | $113.28M | $419.88M | $185.62M | $65.05M | $90.21M | 5.92× |
| 2019-06-30 | $376.71M | $105.77M | $119.87M | $189.88M | $66.96M | $85.11M | 3.56× |
| 2019-03-31 | $385.03M | $113.97M | $129.25M | $187.12M | $68.66M | $73.82M | 3.38× |
| 2018-12-31 | $352.24M | $115.66M | $113.91M | $175.04M | $63.29M | $71.41M | 3.05× |
| 2018-09-30 | $359.79M | $97.22M | $126.56M | $163.28M | $69.95M | $58.05M | 3.70× |
| 2018-06-30 | $349.47M | $76.11M | $136.25M | $163.55M | $49.68M | $40.81M | 4.59× |
| 2018-03-31 | $402.38M | $82.41M | $203.15M | $148.85M | $50.38M | $26.33M | 4.88× |
| 2018-01-01 | (m) | $88.65M | (m) | (m) | (m) | $33.04M | (m) |
| 2017-12-31 | $493.43M | $86.03M | $272.58M | $167.48M | $53.37M | $33.79M | 5.74× |
| 2017-09-30 | $322.93M | $74.94M | $102.23M | $173.52M | $47.17M | $35.05M | 4.31× |
| 2017-06-30 | $296.36M | $48.02M | $73.49M | $185.12M | $37.75M | $33.96M | 6.17× |
| 2017-03-31 | $294.68M | $39.38M | $76.04M | $177.99M | $40.65M | $34.33M | 7.48× |
| 2016-12-31 | $327.37M | $55.70M | $137.17M | $161.40M | $28.80M | $35.51M | 5.88× |
| 2016-09-30 | $321.24M | $54.25M | $215.40M | $67.29M | $38.55M | $32.66M | 5.92× |
| 2016-06-30 | $149.97M | $55.18M | $75.66M | $35.60M | $38.70M | $24.49M | 2.72× |
| 2016-03-31 | (m) | $49.77M | $111.64M | (m) | $40.47M | $14.02M | (m) |
| 2015-12-31 | (m) | $65.16M | $122.67M | (m) | $48.39M | $14.04M | (m) |
| 2015-09-30 | (m) | $59.44M | $145.47M | (m) | $31.80M | $13.02M | (m) |
| 2015-06-30 | (m) | $52.68M | $145.14M | (m) | $31.83M | $23.43M | (m) |
| 2015-03-31 | (m) | $47.38M | $145.61M | (m) | $36.09M | $20.07M | (m) |
| 2014-12-31 | (m) | $44.30M | $151.19M | (m) | $39.88M | $13.10M | (m) |
| 2014-09-30 | (m) | $47.76M | $146.37M | (m) | $47.15M | $9.66M | (m) |
| 2014-06-30 | (m) | $71.20M | $175.54M | (m) | $41.80M | $8.77M | (m) |
| 2014-03-31 | (m) | $43.12M | $145.61M | (m) | $36.68M | $10.45M | (m) |
| 2013-12-31 | (m) | $42.37M | $149.73M | (m) | $33.07M | $9.46M | (m) |
| 2013-09-30 | (m) | $48.29M | $153.91M | (m) | $34.47M | $5.39M | (m) |
| 2013-06-30 | (m) | $33.85M | $150.94M | (m) | $33.65M | $5.98M | (m) |
| 2013-03-31 | (m) | $42.98M | $148.06M | (m) | $31.11M | $9.20M | (m) |
| 2012-12-31 | (m) | $48.29M | $57.29M | (m) | $33.29M | $14.87M | (m) |
| 2012-09-30 | (m) | $49.34M | $63.44M | (m) | $30.14M | $15.09M | (m) |
| 2012-06-30 | (m) | $43.14M | $70.14M | (m) | $25.59M | $16.43M | (m) |
| 2012-03-31 | (m) | $32.58M | $83.01M | (m) | $26.20M | $14.70M | (m) |
| 2011-12-31 | (m) | $28.00M | $93.95M | (m) | $23.19M | $11.84M | (m) |
| 2011-09-30 | (m) | $24.76M | $103.81M | (m) | $17.27M | $13.12M | (m) |
| 2011-06-30 | (m) | $26.61M | $106.75M | (m) | $20.36M | $15.96M | (m) |
| 2011-03-31 | (m) | (m) | $104.49M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $18.95M | $113.27M | (m) | $16.84M | $11.43M | (m) |
| 2010-09-30 | (m) | (m) | $103.92M | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $118.07M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $128.00M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $56.66M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |